Advertisement
Advertisement
Syndax Pharmaceuticals Inc. (1T3.SG)
Stuttgart - Stuttgart Delayed Price. Currency in EUR
Follow
As of 04:43PM CET. Market open.
Advertisement
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
| Previous Close | 26.00 |
| Open | 25.60 |
| Bid | 25.20 x 0 |
| Ask | 25.40 x 0 |
| Day's Range | 25.40 - 25.60 |
| 52 Week Range | 12.70 - 26.60 |
| Volume | |
| Avg. Volume | 37 |
| Market Cap | N/A |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | Feb 27, 2023 - Mar 03, 2023 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Zacks
Syndax Pharmaceuticals (SNDX) Stock Sinks As Market Gains: What You Should Know
In the latest trading session, Syndax Pharmaceuticals (SNDX) closed at $26.47, marking a -0.45% move from the previous day.
- Zacks
Beat the Market Like Zacks: Boeing, Starbucks, Syndax Pharma in Focus
Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.
- Zacks
Syndax (SNDX) Is a Great Choice for 'Trend' Investors, Here's Why
Syndax (SNDX) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
© 2023 Yahoo. All rights reserved.
